Predictors of response to neoadjuvant chemo-immunotherapy in metaplastic triple-negative breast cancer
Abstract Metaplastic breast cancer (MpBC) treated with standard chemotherapy has low rates of complete pathological response (pCR)(2–23%). In this study, we evaluate the response to neoadjuvant chemo-immunotherapy (NACI) in early-stage MpBC. Thirty-two stage I-III MpBC patients treated with NACI (KE...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Nature Portfolio
2025-10-01
|
| Reeks: | npj Breast Cancer |
| Online toegang: | https://doi.org/10.1038/s41523-025-00816-w |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|